AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32977253 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 32977253 — intervention group
Group type: EXPERIMENTAL
Intervention: Global L‐arginine group (AS1000 and AS2000)
Number of subjects: 120
Study 32977253 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐arginine groups (AS1000 and AS2000) in male infertility subgroup
Number of subjects: 120
Study 35014217 — intervention group
Group type: EXPERIMENTAL
Intervention: GDC-0134 (up to 1200 mg daily)
Number of subjects: 49
Study 35014217 — intervention group
Group type: EXPERIMENTAL
Intervention: GDC-0134
Number of subjects: 49
Study 35014217 — intervention group
Group type: COMPARATOR
Intervention: DLK conditional knockout (cKO) mice
Number of subjects: 49
Study 34416736 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression with instrumented fusion
Number of subjects: 84
Study 34416736 — intervention group
Group type: COMPARATOR
Intervention: Decompression
Number of subjects: 84
Study 32456442 — intervention group
Group type: EXPERIMENTAL
Intervention: EPs 7630, 3 × 20 mg/day for 10 days
Number of subjects: 50
Study 32456442 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin, 3 × 500 mg/day for 10 days
Number of subjects: 50
Study 35901595 — intervention group
Group type: EXPERIMENTAL
Intervention: F/TMP association (1100 ppm F + 3 % TMP)
Number of subjects: 130
Study 35901595 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 % TMP (hydrolyzed or not)
Number of subjects: 130
Study 35901595 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ppm F
Number of subjects: 130
Study 35901595 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 ppm F
Number of subjects: 130
Study 35901595 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 ppm F + 3 % TMP
Number of subjects: 130
Study 35901595 — intervention group
Group type: COMPARATOR
Intervention: F/TMP association
Number of subjects: 130
Study 33581381 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic configuration networks (SCNs) ensemble models
Number of subjects: 0
Study 34642798 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted mediastinoscopic combined with laparoscopic transhiatal esophagectomy (VAME)
Number of subjects: 200
Study 34642798 — intervention group
Group type: COMPARATOR
Intervention: Video-assisted thoracoscopic esophagectomy (VATE)
Number of subjects: 200
Study 32152813 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 3.0 g via subfascial drain
Number of subjects: 60
Study 32152813 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tranexamic acid (TXA) 1.5 g just before wound closure
Number of subjects: 60
Study 32152813 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical and IV TXA
Number of subjects: 60
Study 32943381 — intervention group
Group type: EXPERIMENTAL
Intervention: AC resection arthroplasty (DCR) in shoulders with T2 hyperintensity (HI+)
Number of subjects: 107
Study 32943381 — intervention group
Group type: COMPARATOR
Intervention: Shoulders without T2 hyperintensity (HI−)
Number of subjects: 107
Study 35599154 — intervention group
Group type: COMPARATOR
Intervention: BCG vaccine
Number of subjects: 378
Study 34319137 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vaccination against PNAG
Number of subjects: 0
Study 34319137 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-vaccinated foals)
Number of subjects: 0
Study 32000724 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI oxaliplatin plus systemic FOLFIRI plus targeted therapy (anti-EGFR antibody or bevacizumab)
Number of subjects: 140
Study 32000724 — intervention group
Group type: COMPARATOR
Intervention: Conventional systemic chemotherapy (sys-CT) plus targeted therapy (anti-EGFR or antiangiogenic antibody)
Number of subjects: 140
Study 34982817 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary feeding
Number of subjects: 1791
Study 34982817 — intervention group
Group type: COMPARATOR
Intervention: Counseling alone
Number of subjects: 1791
Study 34224341 — intervention group
Group type: COMPARATOR
Intervention: Placebo delivery forms
Number of subjects: 277
Study 35409483 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support plus daily text messages
Number of subjects: 181
Study 35409483 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging only
Number of subjects: 181
Study 35409483 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 181
Study 35409483 — intervention group
Group type: COMPARATOR
Intervention: Peer support only
Number of subjects: 181
Study 35409483 — intervention group
Group type: COMPARATOR
Intervention: Daily supportive text messages only
Number of subjects: 181
Study 33412465 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib 5 mg twice daily and pembrolizumab 2 mg/kg every 3 weeks
Number of subjects: 52
Study 35509077 — intervention group
Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine (0-2-6 months)
Number of subjects: 200
Study 35509077 — intervention group
Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine (0-2-12 months)
Number of subjects: 200
Study 35509077 — intervention group
Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine (both schedules)
Number of subjects: 200
Study 35509077 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0-2-6 group)
Number of subjects: 200
Study 35509077 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0-2-12 group)
Number of subjects: 200
Study 32181599 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in PDAC patients after surgery
Number of subjects: 6323
Study 32181599 — intervention group
Group type: COMPARATOR
Intervention: Nomograms compared to the 8th edition AJCC staging system
Number of subjects: 6323
Study 34262664 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmentally adapted cognitive processing therapy (D-CPT)
Number of subjects: 44
Study 34955090 — intervention group
Group type: EXPERIMENTAL
Intervention: Touch condition (actual hold touched)
Number of subjects: 0
Study 34955090 — intervention group
Group type: COMPARATOR
Intervention: No-touch condition (actual hold not touched)
Number of subjects: 0
Study 34955090 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Prime condition (SP)
Number of subjects: 0
Study 34955090 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-Prime condition (DP)
Number of subjects: 0
Study 32869586 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of twelve meridian muscle regions and contralateral needling therapy
Number of subjects: 46
Study 32869586 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injection of mecobalamine and oral citicoline sodium capsules
Number of subjects: 46
Study 32366139 — intervention group
Group type: EXPERIMENTAL
Intervention: Industrial beer (4.5% alcohol), 330 ml daily for 3 weeks
Number of subjects: 24
Study 32366139 — intervention group
Group type: EXPERIMENTAL
Intervention: Craft beer (9% alcohol), 330 ml daily for 3 weeks
Number of subjects: 24
Study 32366139 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as the absence of beer consumption)
Number of subjects: 24
Study 35028547 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) - 25% reduction from baseline calorie intake for 24 months
Number of subjects: 218
Study 35028547 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum (AL)
Number of subjects: 218
Study 33297445 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengue seroconversion
Number of subjects: 1071
Study 33297445 — intervention group
Group type: EXPERIMENTAL
Intervention: Seroprevalence of dengue
Number of subjects: 1071
Study 33297445 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with age and gender
Number of subjects: 1071
Study 33297445 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with province and duration of residence
Number of subjects: 1071
Study 33297445 — intervention group
Group type: COMPARATOR
Intervention: Socioeconomic factors and mosquito control methods
Number of subjects: 1071
Study 33105359 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-Body (FB) resistance exercise
Number of subjects: 12
Study 33105359 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-Body (LB) resistance exercise
Number of subjects: 12
Study 33105359 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-Body (UB) resistance exercise
Number of subjects: 12
Study 36461019 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention through 'Care for Child Development Guideline' (5 educational group sessions, each lasting 45 minutes)
Number of subjects: 181
Study 33430922 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint didactic intervention using the Junta de Andalucía School for Patients method
Number of subjects: 312
Study 33430922 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical practice (Control group)
Number of subjects: 312
Study 35900802 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity (HI) bench press protocol (5 sets of 1 rep at 90% of 1RM)
Number of subjects: 13
Study 35900802 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power (POW) bench press protocol (5 sets of 1 rep at 30% of 1RM with maximum explosive intent)
Number of subjects: 13
Study 35900802 — intervention group
Group type: COMPARATOR
Intervention: Control trial (CON)
Number of subjects: 13
Study 33999281 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 856
Study 33999281 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 856
Study 33999281 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 856
Study 35227810 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicompartmental knee arthroplasty (UKA)
Number of subjects: 107
Study 35227810 — intervention group
Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 107
Study 32910549 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 80
Study 32910549 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated chemoradiation (CRT)
Number of subjects: 80
Study 35915802 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition support on a routine basis
Number of subjects: 200
Study 35915802 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition support on a routine basis
Number of subjects: 200
Study 34216395 — intervention group
Group type: EXPERIMENTAL
Intervention: EVR+rCNI
Number of subjects: 293
Study 34216395 — intervention group
Group type: COMPARATOR
Intervention: MPA+sCNI
Number of subjects: 293
Study 32716291 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan oral gel (test)
Number of subjects: 47
Study 32716291 — intervention group
Group type: COMPARATOR
Intervention: Rizatriptan oral lyophilisate (reference)
Number of subjects: 47
Study 32716291 — intervention group
Group type: EXPERIMENTAL
Intervention: Test vs Reference (T/R)
Number of subjects: 47
Study 32716291 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs)
Number of subjects: 47
Study 32716291 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatability assessment of the new product
Number of subjects: 47
Study 35017204 — intervention group
Group type: EXPERIMENTAL
Intervention: EVT‐alone
Number of subjects: 656
Study 34521975 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal Adverse Event Severity Scale (NAESS)
Number of subjects: 60
Study 34521975 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic and AE-specific NAESS tables
Number of subjects: 60
Study 36041760 — intervention group
Group type: EXPERIMENTAL
Intervention: FDCC integrated hub model of care
Number of subjects: 0
Study 36041760 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32778372 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based classroom gaming
Number of subjects: 0
Study 32778372 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33728385 — intervention group
Group type: EXPERIMENTAL
Intervention: Aayudh Advance (herbal formulation)
Number of subjects: 74
Study 33728385 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care treatment
Number of subjects: 74
Study 32586639 — intervention group
Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) with 3.2 mm diameter
Number of subjects: 15
Study 32586639 — intervention group
Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) with 6.4 mm diameter
Number of subjects: 15
Study 32586639 — intervention group
Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) with 9.6 mm diameter
Number of subjects: 15
Study 32586639 — intervention group
Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) for 5 minutes
Number of subjects: 15
Study 32586639 — intervention group
Group type: COMPARATOR
Intervention: Historical patient group with 2 minutes phonation training
Number of subjects: 15
Study 32560737 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Superior Approach (DSA)
Number of subjects: 80
Study 32560737 — intervention group
Group type: COMPARATOR
Intervention: Posterior Approach (PA)
Number of subjects: 80
Study 33484291 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercises at the anaerobic threshold (AT)
Number of subjects: 57
Study 33484291 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercises above the anaerobic threshold (Over AT)
Number of subjects: 57
Study 33484291 — intervention group
Group type: EXPERIMENTAL
Intervention: Over AT group
Number of subjects: 57
Study 33484291 — intervention group
Group type: COMPARATOR
Intervention: Control group (AT group)
Number of subjects: 57
Study 35051978 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour repositioning interval
Number of subjects: 992
Study 35051978 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour repositioning interval
Number of subjects: 992
Study 35051978 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour repositioning interval
Number of subjects: 992
Study 35051978 — intervention group
Group type: COMPARATOR
Intervention: Baseline (before intervention)
Number of subjects: 992
Study 34401778 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystem mapping training combined with post-training sleep consolidation
Number of subjects: 0
Study 34401778 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 35180728 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 44
Study 35180728 — intervention group
Group type: EXPERIMENTAL
Intervention: Long leg cast
Number of subjects: 44
Study 34173157 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency (HF) dTMS
Number of subjects: 45
Study 34173157 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study 36056399 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic walking rehabilitation treatment (experimental group)
Number of subjects: 144
Study 36056399 — intervention group
Group type: COMPARATOR
Intervention: Conventional gait rehabilitation treatment (control group)
Number of subjects: 144
Study 33836919 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcephaly associated with Zika virus (MZV)
Number of subjects: 40
Study 35810173 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude expression treatment (GET)
Number of subjects: 0
Study 35810173 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 34388099 — intervention group
Group type: EXPERIMENTAL
Intervention: AI imaging predictor (AIP)
Number of subjects: 869
Study 34388099 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated clinical and AI imaging nomogram (ClAIN)
Number of subjects: 869
Study 34388099 — intervention group
Group type: EXPERIMENTAL
Intervention: ClAIN
Number of subjects: 869
Study 33221898 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prescriptions during inpatient admissions
Number of subjects: 1254
Study 33221898 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prescriptions in neonatal sepsis
Number of subjects: 1254
Study 33221898 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prescriptions in lower respiratory tract infection (LRTI)
Number of subjects: 1254
Study 33221898 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of 'Watch' antimicrobials in neonatal sepsis
Number of subjects: 1254
Study 33221898 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of 'Watch' antimicrobials in LRTI
Number of subjects: 1254
Study 33221898 — intervention group
Group type: COMPARATOR
Intervention: Comparison of antimicrobial prescription rates
Number of subjects: 1254
Study 35027160 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized positive mental imagery exercise about future public speaking
Number of subjects: 43
Study 35027160 — intervention group
Group type: COMPARATOR
Intervention: No-task (control group)
Number of subjects: 43
Study 34417443 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (0.50 mg)
Number of subjects: 55
Study 34417443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 32790593 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 22
Study 32790593 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 22
Study 35240084 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparametric ultrasound
Number of subjects: 370
Study 35240084 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparametric MRI
Number of subjects: 370
Study 35240084 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both tests
Number of subjects: 370
Study 32049889 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tobramycin at 8:00 hours
Number of subjects: 25
Study 32049889 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tobramycin at 22:00 hours
Number of subjects: 25
Study 34882964 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (n = 410)
Number of subjects: 821
Study 34882964 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 411)
Number of subjects: 821
Study 36260279 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands‐eyes‐mouth distraction technique (HEM‐DT)
Number of subjects: 52
Study 36260279 — intervention group
Group type: COMPARATOR
Intervention: Covering patient's vision technique (CPV‐T)
Number of subjects: 52
Study 34399696 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted randomization procedures targeting 1:1 allocation
Number of subjects: 0
Study 34399696 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate‐adjusted analysis
Number of subjects: 0
Study 34399696 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization-based tests
Number of subjects: 0
Study 32398119 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% oxygen during surgery and for 2 h postoperatively
Number of subjects: 260
Study 32398119 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen during surgery and for 2 h postoperatively
Number of subjects: 260
Study 33600729 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting bronchodilators
Number of subjects: 579
Study 33600729 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (ICS) therapy
Number of subjects: 579
Study 33600729 — intervention group
Group type: COMPARATOR
Intervention: Severe exacerbation
Number of subjects: 579
Study 32959409 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusions with storage age of 1 to 7 days (majority 4 or 5 days)
Number of subjects: 497
Study 32959409 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusions with fresher storage age
Number of subjects: 497
Study 35180966 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Number of subjects: 10
Study 34891528 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-Augmented Visual Feedback (EA)
Number of subjects: 0
Study 34891528 — intervention group
Group type: COMPARATOR
Intervention: Standard visual feedback (no EA)
Number of subjects: 0
Study 36127418 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged cycling at 90% of the estimated power output at first ventilatory threshold (VT1) for two hours
Number of subjects: 14
Study 33561426 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 4 mg administered preemptively
Number of subjects: 22
Study 33561426 — intervention group
Group type: COMPARATOR
Intervention: Control side (no intervention)
Number of subjects: 22
Study 32758281 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led health coaching intervention
Number of subjects: 0
Study 34786952 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment (PRF) with pregabalin
Number of subjects: 40
Study 34786952 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin alone
Number of subjects: 40
Study 33198711 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 33198711 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0
Study 33198711 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 0
Study 34758073 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg daily aspirin
Number of subjects: 19114
Study 34758073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 32487077 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over the leg area of the primary motor cortex (M1) for 20 minutes
Number of subjects: 46
Study 32487077 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 46
Study 35896392 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous ligament fixation (SSF)
Number of subjects: 81
Study 32677716 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic argon plasma coagulation (APC)
Number of subjects: 54
Study 32677716 — intervention group
Group type: COMPARATOR
Intervention: Non-APC (control group)
Number of subjects: 54
Study 32455135 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate or high levels of strength training
Number of subjects: 6561
Study 32455135 — intervention group
Group type: COMPARATOR
Intervention: No strength training
Number of subjects: 6561
Study 35227647 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled AZD5634 (600 µg)
Number of subjects: 64